Sign in
Taking peoplePhase 4

Tadalafil for womb lining thickness in women having frozen embryo transfer for infertility

Tests tadalafil in women with unexplained infertility undergoing IVF with frozen embryos.

Key facts

Who runs it
Beni-Suef University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Status
Recruiting
Phase
Phase 4
People taking part
100 people, planned
Started
1 Oct 2023
Planned end
30 Apr 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Tadalafil 5mg
  • estradiol valerate 2 mg
Record updated
30 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with unexplained infertility having IVF who have good quality day five frozen embryos. It tests whether Tadalafil helps the womb lining and frozen embryo transfer.

Age
18 Years to 43 Years
Sex
Female only
Disease stage
Unexplained infertility, using IVF with frozen embryo transfer.
Earlier treatment
Must already have good quality day five frozen embryos.

Main reasons for not taking part

  • Low blood pressure (less than 90/50)
  • History of stroke
  • History of heart attack (myocardial infarction)

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • has good quality day five frozen embryos

Who cannot take part

  • history of stroke or myocardial infarction
  • hypotension (blood pressure less than 90/50) and

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 43 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

investigate the effect of different vasodilators as Tadalafil in women with unexplained infertility using IVF

The 2 groups in the trial

  • (control)Existing treatment, for comparison

    Patients received estradiol valerate 2 mg. in form of (Cycloprogynova® Bayer Shering Pharma) white pills starting dose is one pill T.I.D may be increased to two pills T.I.D according to endometrial thickness in day 9 measured by vaginal ultrasound.

    Treatment: estradiol valerate 2 mg

  • tadalafil 5 mgTreatment being tested

    once daily in form of (tadanerfi 5® Nerhadou international5 co.) daily in addition to the above treatment protocol from the first day of the cycle until the day of starting progesterone

    Treatment: Tadalafil 5mg

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Plain-language title
Tadalafil for womb lining thickness in women having frozen embryo transfer for infertilityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT07499804, who can take part
Record updated
30 March 2026